基于酵母的CRISPR基因组编辑系统的开发
Xiaohu Zhang1, Jingru Zhu1, Di Zhang1,2
1State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Frontiers in microbiology
|September 2, 2025
概括
研究人员开发了一种用于猫科冠状病毒 (FCoV) 的CRISPR基因组编辑系统,以帮助猫科传染性周周周炎 (FIP) 研究. 这种工具有助于了解FCoV的发病性,并开发新的FIP诊断和疫苗.
科学领域:
- 病毒学
- 分子生物学
- 遗传学
背景情况:
- 猫感染性腹膜炎 (FIP),是由猫冠状病毒 (FCoV) 引起的,是猫的致命疾病.
- 由于缺乏诊断标准,疫苗和治疗方法,目前的FIP研究面临挑战.
- 基因组编辑工具包对于了解FCoV复制,病变发生和识别治疗点至关重要.
研究的目的:
- 开发一个强大的FCoV基因组编辑系统.
- 为研究FCoV进行基因操纵.
- 为FIP疫苗开发和FCoV研究创建一个平台.
主要方法:
- 开发了一个基于酵母的CRISPR基因组编辑系统.
- 该系统与TAR生成的FCoV传染性克隆兼容.
- 能够高效准确地进行基因删除,插入和点突变.
主要成果:
- 成功建立了针对FCoV的功能CRISPR基因组编辑系统.
- 在FCoV基因组的基因编辑中表现出高效率和准确性.
- 该系统促进了FCoV传染性克隆中的各种遗传修饰.
结论:
- 开发的CRISPR系统是FCoV研究和了解FIP病变的一个有价值的工具.
- 这一平台可以加速新型FIP疫苗和向治疗的开发.
- 该方法为其他冠状病毒的基因组编辑提供了潜在的策略.
相关概念视频
CRISPR/Cas9 Genome Editing
211
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
211
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K


